摘要
目的:通过对乙肝肝硬变腹水临床路径实施情况的分析,评价临床路径应用于临床的效果。方法:选择我院120例乙肝肝硬变腹水患者,随机分为观察组60例与对照组60例,观察组采取临床路径管理方案,对照组采取传统临床管理方案,比较2组患者在住院时间、医疗费用、健康知识掌握情况及患者满意度方面的差异。结果:观察组患者的平均住院时间为14.58±5.14 d,住院总费用为11 856.62±457.53元,患者满意度为96.53±7.25分,健康知识掌握度评分为28.46±3.52分;对照组患者的平均住院时间为17.32±4.81 d,住院总费用为14 720.45±524.32元,患者满意度为91.34±8.62分,健康知识掌握度评分为24.13±3.67分。2组分别比较均有显著性差异(P<0.05)。结论:采用临床路径管理乙肝肝硬变腹水患者能显著缩短住院时间,减少医疗费用,提高患者的满意度及健康知识掌握度。
Objective：To evaluate the implementation effect of clinical pathway （CP） in Hepatitis B patients with Cirrhosis Ascites. Methods ：120 cases of hepatitis B patients with Cirrhosis Ascites were randomly divided into treatment group and the control group, the treatment group were treated with the CP program, the control group were treated with the traditional program, it were observed in length of stay, medical costs, health knowledge and differences in patient satisfaction. Results： In treatment group the average length of stay was 14.58 ± 5. 14 days, the total cost of hospitalization was 11 856. 62 ± 457. 53 yuan, patient satisfaction was 96.53 ± 7.25, health knowledge score was 28.46 ± 3.52; in the control group, in sequence there were 17. 32 ± 4. 81 days, 14 720.45 ± 524.32 Yuan, 91.34 ±8.62, 24.13 ±3.67, the difference was statistically significant （ P 〈 0.05）. Conclusion： Using CP management of hepatitis B patients with Cirrhosis Ascites can significantly shorten the length of hospital stay, reduce medical costs, improve patient satisfaction and degree of health knowledge.
出处
《现代临床医学》
2012年第1期20-22,共3页
Journal of Modern Clinical Medicine
关键词
乙肝
肝硬变腹水
临床路径
hepatitis B
cirrhosis ascites
clinical pathway
